NIH Guide for Grants and Contracts
May 24, 2019
Weekly NIH Funding Opportunities and Notices

Policy Notices

General Notices

Notice of Changes to Funding Opportunities

Notices of Intent to Publish

Notices of Special Interest

Funding Opportunities

  • Postdoctoral Research Associate Training (PRAT) Program (Fi2)
    (PAR-19-286)
    National Institute of General Medical Sciences
    Application Receipt Date(s): October 2, 2019; October 2, 2020; October 4, 2021, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)
    (PAR-19-287)
    National Cancer Institute
    Application Receipt Date(s): July 15, 2019, November 15, 2019, July 10, 2020, November 17, 2020, July 9, 2021, November 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging (U24 Clinical Trials Not Allowed)
    (RFA-AG-20-043)
    National Institute on Aging
    Application Receipt Date(s): July 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

  • Workshops on the Use of Adolescent Brain Cognitive Development (ABCD) Data (R25 Clinical Trial Not Allowed)
    (RFA-DA-20-001)
    National Institute on Drug Abuse
    National Institute of Mental Health
    Application Receipt Date(s): October 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (SBIR) (R44 Clinical Trial Not Allowed)
    (RFA-GM-19-001)
    National Institute of General Medical Sciences
    National Center for Advancing Translational Sciences
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): January 6, 2020, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement

  • Drug Screening with Biofabricated 3-D Skin Disease Tissue Models (U18 Clinical Trial Not Allowed)
    (RFA-TR-19-020)
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): July 31, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.